Advancements in the therapeutic potential of sesquiterpenoids for the treatment of hepatocellular carcinoma (Review)
- Authors:
- Yan Li
- Xin Du
- Jingxin Mao
-
Affiliations: Chongqing Medical and Pharmaceutical College, Chongqing 400030, P.R. China - Published online on: June 19, 2025 https://doi.org/10.3892/ijo.2025.5766
- Article Number: 60
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Hepatocellular carcinoma. Nat Rev Dis Primers. 7:72021. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W and Wang C: Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 20:203–222. 2023. View Article : Google Scholar | |
|
Ramos S: Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol Nutr Food Res. 52:507–526. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
García Rodríguez LA, Martín-Pérez M, Hennekens CH, Rothwell PM and Lanas A: Bleeding risk with long-term Low-dose aspirin: A systematic review of observational studies. PLoS One. 11:e01600462016. View Article : Google Scholar : PubMed/NCBI | |
|
Laidlaw TM and Cahill KN: Current knowledge and management of hypersensitivity to aspirin and NSAIDs. J Allergy Clin Immunol Pract. 5:537–545. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ren W, Wang W and Guo Y: Analysis of adverse reactions of aspirin in prophylaxis medication based on FAERS database. Computational Mathematical Methods Med. 2022:78822772022. View Article : Google Scholar | |
|
Anwanwan D, Singh SK, Singh S, Saikam V and Singh R: Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020. View Article : Google Scholar : | |
|
Sayiner M, Golabi P and Younossi ZM: Disease burden of hepatocellular carcinoma: A global perspective. Dig Dis Sci. 64:910–917. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chopra B and Dhingra AK: Natural products: A lead for drug discovery and development. Phytother Res. 35:4660–4702. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng C, Zhuo S, Zhang B, Zhao X, Liu Y, Liao C, Quan J, Li Z, Bode AM, Cao Y and Luo X: Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer. Int J Biol Sci. 15:1654–1663. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Newman DJ and Cragg GM: Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 83:770–803. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP and Wang YT: Terpenoids: Natural products for cancer therapy. Expert Opin Investig Drugs. 21:1801–1818. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Atanasov AG, Zotchev SB, Dirsch VM; International Natural Product Sciences Taskforce; Supuran CT: Natural products in drug discovery: Advances and opportunities. Nat Rev Drug Discov. 20:200–216. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Langhasova L, Hanusova V, Rezek J, Stohanslova B, Ambroz M, Kralova V, Vanek T, Lou JD, Yun ZL, Yang J and Skalova L: Essential oil from Myrica rubra leaves inhibits cancer cell proliferation and induces apoptosis in several human intestinal lines. Industrial Crops Products. 59:20–26. 2014. View Article : Google Scholar | |
|
Wang J, Li X, Bai Z, Chi BX, Wei Y and Chen X: Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/GSK3β/cyclin D1 pathway. J Ethnopharmacol. 210:1–9. 2018. View Article : Google Scholar | |
|
Barcellos Marini M, Rodrigues de Freitas W, Lacerda da Silva Machado F, Correa Ramos Leal I, Ribeiro Soares A, Masahiko Kanashiro M and Frazão Muzitano M: Cytotoxic activity of halogenated sesquiterpenes from Laurencia dendroidea. Phytother Res. 32:1119–1125. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Choo SJ, Ryoo IJ, Kim KC, Na M, Jang JH, Ahn JS and Yoo ID: Hypo-pigmenting effect of sesquiterpenes from Inula britannica in B16 melanoma cells. Arch Pharm Res. 37:567–574. 2014. View Article : Google Scholar | |
|
Liu W, Wang X, Sun J, Yang Y, Li W and Song J: Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis. Onco Targets Ther. 10:453–461. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Wang C, Wu Z, Xue J, Shen B, Zuo W, Wang Z and Wang SL: Artesunate suppresses the growth of prostatic cancer cells through inhibiting androgen receptor. Biol Pharm Bull. 40:479–485. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mitsui T, Hayashi K, Kawai M, Kido M, Tani H, Takaoka D, Matsuura N and Nozaki H: Culcitiolides E-J, six new eremophilane-type sesquiterpene derivatives from Senecio culcitioides. Chem Pharm Bull (Tokyo). 61:816–822. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ko W, Park JS, Kim KW, Kim J, Kim YC and Oh H: Nardosinone-type sesquiterpenes from the hexane fraction of Nardostachys jatamansi attenuate NF-κB and MAPK signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells. Inflammation. 41:1215–1228. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cheikh IA, El-Baba C, Youssef A, Saliba NA, Ghantous A and Darwiche N: Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention. Expert Opin Drug Discov. 17:1377–1405. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Matos MS, Anastácio JD and Nunes dos Santos C: Sesquiterpene lactones: Promising natural compounds to fight inflammation. Pharmaceutics. 13:9912021. View Article : Google Scholar : PubMed/NCBI | |
|
Merfort I: Perspectives on sesquiterpene lactones in inflammation and cancer. Curr Drug Targets. 12:1560–1573. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hohmann MSN, Longhi-Balbinot DT, Guazelli CFS, Navarro SA, Zarpelon AC, Casagrande R, Arakawa NS and Verri WA Jr: Chapter 7-Sesquiterpene lactones: Structural diversity and perspectives as anti-inflammatory molecules. Studies Natu Products Chemistry. 49:243–264. 2016. View Article : Google Scholar | |
|
Ivanescu B, Miron A and Corciova A: Sesquiterpene lactones from Artemisia Genus: Biological activities and methods of analysis. J Anal Methods Chem. 2015:2476852015. View Article : Google Scholar : PubMed/NCBI | |
|
Ooko E, Saeed MEM, Kadioglu O, Sarvi S, Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T: Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Efferth T: Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets. 7:407–421. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jia J, Qin Y, Zhang L, Guo C, Wang Y, Yue X and Qian J: Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis. Mol Med Report. 13:4461–4468. 2016. View Article : Google Scholar | |
|
Zhang M, Wang L, Liu W, Wang T, De Sanctis F, Zhu L, Zhang G, Cheng J, Cao Q, Zhou J, et al: Targeting inhibition of accumulation and function of Myeloid-derived suppressor cells by artemisinin via PI3K/AKT, mTOR, and MAPK pathways enhances Anti-PD-L1 immunotherapy in melanoma and liver tumors. J Immunol Res. 2022:22534362022.PubMed/NCBI | |
|
Tyagi N, Sharma GN, Shrivastava B, Saxena P and Kumar N: Medicinal plants: Used in Anti-cancer treatment. Int J Res Dev Pharmacy Life Sci. 6:2732–2739. 2017. | |
|
He GN, Bao NR, Wang S, Xi M, Zhang TH and Chen FS: Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Des Devel Ther. 15:3965–3978. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
AbouAitah K and Lojkowski W: Delivery of natural agents by means of mesoporous silica nanospheres as a promising anticancer strategy. Pharmaceutics. 13:1432021. View Article : Google Scholar : PubMed/NCBI | |
|
Weifeng T, Feng S, Xiangji L, Changqing S, Zhiquan Q, Huazhong Z, Peining Y, Yong Y, Mengchao W, Xiaoqing J and Wan-Yee L: Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine. 18:158–162. 2011. View Article : Google Scholar | |
|
Zhang CZ, Zhang H, Yun J, Chen GG and Lai PB: Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol. 83:1278–1289. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Vandewynckel YP, Laukens D, Geerts A, Vanhove C, Descamps B, Colle I, Devisscher L, Bogaerts E, Paridaens A, Verhelst X, et al: Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent. Eur J Gastroenterol Hepatol. 26:861–870. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ilamathi M, Santhosh S and Sivaramakrishnan V: Artesunate as an anti-cancer agent targets stat-3 and favorably suppresses hepatocellular carcinoma. Curr Top Med Chem. 16:2453–2463. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wu J, Liu S, Xing Y, Min M, Runpeng Z, Jun X and Dong H: Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma. Biochem Biophysical Res Commun. 519:41–45. 2019. View Article : Google Scholar | |
|
Dong W, Ma WJ, Ma YB, Li FJ, Li TZ, Wang YC, He XF, Geng CN, Zhang XM and Chen JJ: Guaiane-type sesquiterpenoid dimers from Artemisia zhongdianensis and antihepatoma carcinoma activity via the p38MAPK pathway. Chin J Chemistry. 41:2453–2468. 2023. View Article : Google Scholar | |
|
Gao Z, Ma WJ, Li TZ, Ma YB, Hu J, Huang XY, Geng CA, He XF, Zhang XM and Chen JJ: Artemidubolides A-T, cytotoxic unreported guaiane-type sesquiterpenoid dimers against three hepatoma cell lines from Artemisia dubia. Phytochemistry. 202:1132992022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Q, Zhang T, Ke CQ, Tang C, Yao S, Lin L and Ye Y: Sesquiterpene lactone dimers from Artemisia lavandulifolia inhibit interleukin-1β production in macrophages through activating autophagy. Bioorg Chem. 105:1044512020. View Article : Google Scholar | |
|
Su L, Zhang X, Ma Y, Geng C, Huang X, Hu J, Li T, Tang S, Shen C, Gao Z, et al: New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity. Acta Pharm Sin B. 11:1648–1666. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Rasul A, Di J, Millimouno FM, Malhi M, Tsuji I, Ali M, Li J and Li X: Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells. Molecules. 18:9382–9396. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wu ZC, Hui XG, Huo L, Sun DX, Peng W, Zhang Y, Li XB, Ma T, Li WH, Liang J and Sun ZQ: Antiproliferative effects of isoalantolactone in human liver cancer cells are mediated through caspase-dependent apoptosis, ROS generation, suppression of cell migration and invasion and targeting Ras/Raf/MEK signalling pathway. Acta Biochim Pol. 69:299–304. 2022.PubMed/NCBI | |
|
Gu W, Zhao H, Yuan H and Zhao S: Dehydrocostus lactone reduced malignancy of HepG2 human hepatocellular carcinoma cells via Down-regulation of the PI3K/AKT signaling pathway. Bull Exp Biol Med. 174:360–365. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Si H, Genna B, Zhuang X, Wang J, Burenbatu B, Feng Q and Wang H: DaHuangWan targets EGF signaling to inhibit the proliferation of hepatoma cells. PLoS One. 15:e02314662020. View Article : Google Scholar : PubMed/NCBI | |
|
Mao J, Yi M, Tao Y, Huang Y and Chen M: Costunolide isolated from Vladimiria souliei inhibits the proliferation and induces the apoptosis of HepG2 cells. Mol Med Rep. 19:1372–1379. 2019. | |
|
Cui YQ, Liu YJ and Zhang F: The suppressive effects of Britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS. Biochem Biophys Res Commun. 497:916–923. 2018. View Article : Google Scholar | |
|
Wang B, Zhou TY, Nie CH, Wan DL and Zheng SS: Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer. Biochem Biophys Res Commun. 499:156–163. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chai T, Meng XH, Wang CB, Wang K, Ma LM, Shi YP and Yang JL: Narjatamolide, an unusual homoguaiane sesquiterpene lactone from Nardostachys jatamansi. J Org Chem. 86:11006–11010. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Shimizu Y, Polavarapu R, Eskla KL, Nicholson CK, Koczor CA, Wang R, Lewis W, Shiva S, Lefer DJ and Calvert JW: Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK. J Mol Cell Cardiol. 116:29–40. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xu W, Ge K, Guo Y, Zhu W and Liu L: ROS-dependent cell death Induced by parthenolide in human hepatoma cell hepG2. Open Access Library J. 7:1–18. 2020. | |
|
Zhai JD, Li D, Long J, Zhang HL, Lin JP, Qiu CJ, Zhang Q and Chen Y: Biomimetic semisynthesis of arglabin from parthenolide. J Org Chem. 77:7103–7107. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, Yang M, Fan H, Long J, Tong Z, et al: Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem. 55:8757–8769. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Z, Xu J, Sun S, Lin W, Li Y, Lu Q, Li F, Yang Z, Lu Y, Liu W, et al: Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma. Redox Biol. 54:1023512022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong J, Gong W, Chen J, Qing Y, Wu S, Li H, Huang C, Chen Y, Wang Y, Xu Z, et al: Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-γ-mediated NF-кB and AMPK/mTOR signaling. Int Immunopharmacol. 59:197–208. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Y, Chen SJ, Wang JC, Niu HX, Jia QQ, Chen XW, Du XY, Lu L, Huang B, Zhang Q, et al: Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism. Oxid Med Cell Longev. 2015:9340582015. View Article : Google Scholar | |
|
Xu H, Wang J, Wang C, Chang G, Lin Y, Zhang H, Zhang H, Li Q and Pang T: Therapeutic effects of micheliolide on a murine model of rheumatoid arthritis. Mol Med Rep. 11:489–493. 2015. View Article : Google Scholar | |
|
Bian M, Fan R, Zhao S and Liu W: Targeting the thioredoxin system as a strategy for cancer therapy: Miniperspective. J Med Chem. 62:7309–7321. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
An Y, Guo W, Li L, Xu C, Yang D, Wang S, Lu Y, Zhang Q, Zhai J, Fan H, et al: Micheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivo. PLoS One. 10:e01162022015. View Article : Google Scholar : PubMed/NCBI | |
|
Yao S, Ye J, Yin M and Yu R: DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo. Cancer Lett. 483:87–97. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sulistyani N: Screening of anticancer, hepatoprotective and nephroprotective effects of ethanol extract of Elephantopus scaber L. Pak J Pharm Sci. 33:901–907. 2020.PubMed/NCBI | |
|
Fu L, Pei D, Yu M, Shang H, Si JG, Zhang HW, Zhang T and Zou ZM: New phenolic acids from the whole herb of Elephantopus scaber Linn. and their anti-inflammatory activity. Nat Prod Res. 35:3667–3674. 2021. View Article : Google Scholar | |
|
Ariesta I and Sukma MG: Extract of Elephantopus scaber as therapy for insulin resistance by decreasing damage of heart and Liver in STZ-Na induced diabetic rats (Rattus novergicus). Am Heart J. 229:1682020. View Article : Google Scholar | |
|
Divya GS, Mansoor KP, Rasheed SP and Kumar A: PPAR gamma agonists: An effective strategy for cancer treatment. J Pharm Sci Innov. 2:1–3. 2013. View Article : Google Scholar | |
|
Bich Ngoc TT, Hoai Nga NT, My Trinh NT, Thuoc TL and Phuong Thao DT: Elephantopus mollis Kunth extracts induce antiproliferation and apoptosis in human lung cancer and myeloid leukemia cells. J Ethnopharmacol. 263:1132222020. View Article : Google Scholar : PubMed/NCBI | |
|
Beeran AA, Maliyakkal N, Rao CM and Udupa N: The enriched fraction of Elephantopus scaber Triggers apoptosis and inhibits Multi-drug resistance transporters in human epithelial cancer cells. Pharmacogn Mag. 11:257–268. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mehmood T, Maryam A, Zhang H, Li Y, Khan M and Ma T: Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction. Biofactors. 43:63–72. 2017. View Article : Google Scholar | |
|
Bai M, Chen JJ, Xu W, Dong SH, Liu QB, Yao GD, Lin B, Huang XX and Song SJ: Germacranolides from Elephantopus scaber L. and their cytotoxic activities. Phytochemistry. 178:1124792020. View Article : Google Scholar : PubMed/NCBI | |
|
Bai M, Chen JJ, Xu W, Dong SH, Liu QB, Lin B, Huang XX, Yao GD and Song SJ: Elephantopinolide AP, germacrane-type sesquiterpene lactones from Elephantopus scaber induce apoptosis, autophagy and G2/M phase arrest in hepatocellular carcinoma cells. Eur J Med Chem. 198:1123622020. View Article : Google Scholar | |
|
Mehmood T, Maryam A, Tian X, Khan M and Ma T: Santamarine inhibits NF-кB and STAT3 activation and induces apoptosis in HepG2 liver cancer cells via oxidative stress. J Cancer. 8:3707–3717. 2017. View Article : Google Scholar : | |
|
Kim JK, Cho IJ, Kim EO, Lee DG, Jung DH, Ki SH, Ku SK and Kim SC: Hemistepsin A inhibits T0901317-induced lipogenesis in the liver. BMB Rep. 54:1062021. View Article : Google Scholar : | |
|
Kim JK, Han NR, Park SM, Jegal KH, Jung JY, Jung EH, Kim EO, Kim D, Jung DH, Lee JR, et al: Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and Akt. Food Chem Toxicol. 135:1110442020. View Article : Google Scholar | |
|
Kim JK, Cho IJ, Kim EO, Jung DH, Ku SK and Kim SC: The effects of Hemistepta lyrata Bunge (Bunge) fractionated extract on liver X receptor α-dependent lipogenic genes in hepatocyte-derived cells. Herbal Formula Sci. 28:255–269. 2020. | |
|
Kim JK, Lee JE, Jung EH, Jung JY, Jung DH, Ku SK, Cho IJ and Kim SC: Hemistepsin A ameliorates acute inflammation in macrophages via inhibition of nuclear factor-κB and activation of nuclear factor erythroid 2-related factor 2. Food Chem Toxicol. 111:176–188. 2018. View Article : Google Scholar | |
|
Baek SY, Hwang UW, Suk HY and Kim YW: Hemistepsin a inhibits cell proliferation and induces G0/G1-Phase arrest, cellular senescence and apoptosis via the AMPK and p53/p21 signals in human hepatocellular carcinoma. Biomolecules. 10:7132020. View Article : Google Scholar : PubMed/NCBI | |
|
Cho IJ, Kim JK, Kim EO, Park SM, Kim SC, Ki SH and Ku SK: Hemistepsin A induces apoptosis of hepatocellular carcinoma cells by downregulating STAT3. Int J Mol Sci. 22:47432021. View Article : Google Scholar : PubMed/NCBI | |
|
Nibret E, Youns M, Krauth-Siegel RL and Wink M: Biological activities of x1anthatin from Xanthium strumarium leaves. Phytother Res. 25:1883–1890. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kovács A, Vasas A, Forgo P, Réthy B, Zupkó I and Hohmann J: Xanthanolides with antitumour activity from Xanthium italicum. Z Naturforsch C J Biosci. 64:343–349. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ramírez-Erosa I, Huang Y, Hickie RA, Sutherland RG and Barl B: Xanthatin and xanthinosin from the burs of Xanthium strumarium L. as potential anticancer agents. Can J Physiol Pharmacol. 85:1160–1172. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Shi T, Zhang L, Cheng Q, Yu JS, Liu J, Shen YJ, Feng XJ and Shen YX: Xanthatin induces apoptosis by activating endoplasmic reticulum stress in hepatoma cells. Eur J Pharmacol. 843:1–11. 2019. View Article : Google Scholar | |
|
Kuck K, Jürgenliemk G, Lipowicz B and Heilmann J: Sesquiterpenes from myrrh and their ICAM-1 inhibitory activity in vitro. Molecules. 26:422020. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Zheng BB, Ma LS, Sun X, Chang JJ, Xie WD and Li X: Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway. Acta Pharmacol Sin. 35:1311–1322. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Su LH, Ma WJ, Ma YB, Li TZ, Geng CA, Dong W, He XF, Zhang XM and Chen JJ: Artemiprincepsolides A-F, Novel Germacrane-guaiane and Eudesmane-guaiane Sesquiterpenoid Dimers from Artemisia princeps and Their Antihepatoma Activity. Chin J Chem. 41:2648–2656. 2023. View Article : Google Scholar | |
|
Wu H, Wu H, Wang W, Liu TT, Qi MG, Feng JC, Li XY and Liu Y: Insecticidal activity of sesquiterpene lactones and monoterpenoid from the fruits of Carpesium abrotanoides. Industrial Crops Products. 92:77–83. 2016. View Article : Google Scholar | |
|
Wang F, Yang K, Ren FC and Liu JK: Sesquiterpene lactones from Carpesium abrotanoides. Fitoterapia. 80:21–24. 2009. View Article : Google Scholar | |
|
Lee J, Min B, Lee S, Na M, Kwon B, Lee C, Kim Y and Bae K: Cytotoxic sesquiterpene lactones from Carpesium abrotanoides. Planta Med. 68:745–747. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C, Yuan C and Jia Z: Xanthanolides, Germacranolides, and Other Constituents from Carpesium longifolium. J Nat Prod. 66:1554–1557. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yan Y, Chen J, Peng M, Zhang X, Feng E, Li Q, Guo B, Ding X, Zhang Y and Tang L: Sesquiterpenes from Carpesium faberi triggered ROS-induced apoptosis and protective autophagy in hepatocellular carcinoma cells. Phytochemistry. 214:1138052023. View Article : Google Scholar : PubMed/NCBI | |
|
Lo Cantore P, Iacobellis NS, De Marco A, Capasso F and Senatore F: Antibacterial activity of Coriandrum sativum L. and Foeniculum vulgare Miller var. vulgare (Miller) essential oils. J Agric Food Chem. 52:7862–7866. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Emamghoreishi M, Khasaki M and Aazam MF: Coriandrum sativum: Evaluation of its anxiolytic effect in the elevated plus-maze. J Ethnopharmacol. 96:365–370. 2005. View Article : Google Scholar | |
|
Bickers D, Calow P, Greim H, Hanifin JM, Rogers AE, Saurat JH, Sipes IG, Smith RL and Tagami H: A toxicologic and dermatologic assessment of linalool and related esters when used as fragrance ingredients. Food Chem Toxicol. 41:919–942. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Usta J, Kreydiyyeh S, Knio K, Barnabe P, Bou-Moughlabay Y and Dagher S: Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels. Chem Biol Interact. 180:39–46. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Simamora A, Timotius KH, Yerer MB, Setiawan H and Mun'im A: Xanthorrhizol, a potential anticancer agent, from Curcuma xanthorrhiza Roxb. Phytomedicine. 105:1543592022. View Article : Google Scholar : PubMed/NCBI | |
|
Tee TT, Cheah YH, Meenakshii N, Mohd Sharom MY and Azimahtol Hawariah LP: Xanthorrhizol induced DNA fragmentation in HepG2 cells involving Bcl-2 family proteins. Biochem Biophys Res Commun. 420:834–838. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fonseca DV, Salgado PR, de Carvalho FL, Salvadori MG, Penha AR, Leite FC, Borges CJ, Piuvezam MR, Pordeus LC, Sousa DP and Almeida RN: Nerolidol exhibits antinociceptive and anti-inflammatory activity: Involvement of the GABAergic system and proinflammatory cytokines. Fundam Clin Pharmacol. 30:14–22. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Krist S, Banovac D, Tabanca N, Wedge DE, Gochev VK, Wanner J, Schmidt E and Jirovetz L: Antimicrobial activity of nerolidol and its derivatives against airborne microbes and further biological activities. Nat Prod Commun. 10:143–148. 2015.PubMed/NCBI | |
|
Chan WK, Tan LT, Chan KG, Lee LH and Goh BH: Nerolidol: A sesquiterpene alcohol with Multi-faceted pharmacological and biological activities. Molecules. 21:5292016. View Article : Google Scholar : PubMed/NCBI | |
|
Biazi BI, Zanetti TA, Baranoski A, Corveloni AC and Mantovani MS: Cis-Nerolidol induces endoplasmic reticulum stress and cell death in human hepatocellular carcinoma cells through extensive CYP2C19 and CYP1A2 oxidation. Basic Clin Pharmacol Toxicol. 121:334–341. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sharifi-Rad M, Nazaruk J, Polito L, Morais-Braga MFB, Rocha JE, Coutinho HDM, Salehi B, Tabanelli G, Montanari C, Del Mar Contreras M, et al: Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications. Microbiol Res. 215:76–79. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Eddin LB, Jha NK, Goyal SN, Agrawal YO, Subramanya SB, Bastaki SMA and Ojha S: Health benefits, pharmacological effects, molecular mechanisms, and therapeutic potential of α-bisabolol. Nutrients. 14:13702022. View Article : Google Scholar | |
|
Kreuger MRO, Grootjans S, Biavatti MW, Vandenabeele P and D'Herde K: Sesquiterpene lactones as drugs with multiple targets in cancer treatment: Focus on parthenolide. Anticancer Drugs. 23:883–896. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Wang W, Fang B, Ma F, Zheng Q, Deng P, Zhao S, Chen M, Yang G and He G: Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 698:95–102. 2013. View Article : Google Scholar | |
|
Liu YY, Zheng Q, Fang B, Wang W, Ma FY, Roshan S, Banafa A, Chen MJ, Chang JL, Deng XM, et al: Germacrone induces apoptosis in human hepatoma HepG2 cells through inhibition of the JAK2/STAT3 signalling pathway. Med Sci. 33:339–345. 2013. | |
|
Na-Bangchang K, Plengsuriyakam T and Karbwang J: Research and development of atractylodes lancea (Thunb) DC. As a promising candidate for cholangiocarcinoma chemotherapeutics. Evid Based Complement Alternat Med. 2017:59292342017. View Article : Google Scholar | |
|
Cheng Y, Mai JY, Hou TL, Ping J and Chen JJ: Antiviral activities of atractylon from Atractylodis Rhizoma. Mol Med Rep. 14:3704–3710. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Meng H, Li GY, Dai RH, Ma Y, Zhang K, Zhang C, Li X and Wang J: Chemical constituents of Atractylodes chinensis (DC.) koidz. Biochem Syst Ecol. 38:1220–1223. 2010. View Article : Google Scholar | |
|
Cheng Y, Chen T, Yang X, Xue J and Chen J: Atractylon induces apoptosis and suppresses metastasis in hepatic cancer cells and inhibits growth in vivo. Cancer Manag Rese. 11:5883–5894. 2019. View Article : Google Scholar | |
|
Cheng Y, Ping J, Chen J, Fu Y, Zhao H and Xue J: Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high-throughput sequencing. Mol Med Rep. 25:1122022. View Article : Google Scholar : | |
|
Cheng SB, Wu LC, Hsieh YC, Wu CH, Chan YJ, Chang LH, Chang CM, Hsu SL, Teng CL and Wu CC: Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. Induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells. J Agric Food Chem. 60:9620–9630. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Abu-Izneid T, Rauf A, Shariati MA, Khalil AA, Imran M, Rebezov M, Uddin MS, Mahomoodally MF and Rengasamy KRR: Sesquiterpenes and their derivatives-natural anticancer compounds: An update. Pharmacol Res. 161:1051652020. View Article : Google Scholar : PubMed/NCBI | |
|
Fraga BM: Natural sesquiterpenoids. Nat Prod Rep. 30:1226–1264. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wu L, Huang X, Kuang Y, Xing Z, Deng X and Luo Z: Thapsigargin induces apoptosis in adrenocortical carcinoma by activating endoplasmic reticulum stress and the JNK signaling pathway: An in vitro and in vivo study. Drug Des Devel Ther. 13:2787–2798. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Andersen TB, López CQ, Manczak T, Martinez K and Simonsen HT: Thapsigargin-from Thapsia L. to mipsagargin. Molecules. 20:6113–6127. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Brennen WN, Rosen DM, Wang H, Isaacs JT and Denmeade SR: Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. J Natl Cancer Inst. 104:1320–1334. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Denmeade SR, Mhaka AM, Rosen DM, Brennen WN, Dalrymple S, Dach I, Olesen C, Gurel B, Demarzo AM, Wilding G, et al: Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Sci Transl Med. 4:140ra862012. View Article : Google Scholar : PubMed/NCBI | |
|
Qu Z, Liu H, Zhang Z, Zheng P, Zhao S and Hou W: Phytochemistry and pharmacology of sesquiterpenoids from Atractylodes DC. Genus Rhizomes. Molecules. 29:13792024. View Article : Google Scholar : PubMed/NCBI | |
|
Tian XH, Hong LL, Jiao WH and Lin HW: Natural sesquiterpene quinone/quinols: Chemistry, biological activity, and synthesis. Nat Prod Reps. 40:718–749. 2023. View Article : Google Scholar | |
|
Shulha O and Zidorn C: Sesquiterpene lactones and their precursors as chemosystematic markers in the tribe Cichorieae of the Asteraceae revisited: An update (2008-2017). Phytochemistry. 163:149–177. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu K, Feng ZM, Yang YN, Jiang JS and Zhang PC: Eight new eudesmane-and eremophilane-type sesquiterpenoids from Atractylodes lancea. Fitoterapia. 114:115–121. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ding HY, Wu YC and Linc HC: Phytochemical and pharmacological studies on Chinese changzhu. J Chin Chem Soc. 47:561–566. 2000. View Article : Google Scholar | |
|
Nakai Y, Kido T, Hashimoto K, Kase Y, Sakakibara I, Higuchi M and Sasaki H: Effect of the rhizomes of Atractylodes lancea and its constituents on the delay of gastric emptying. J Ethnopharmacol. 84:51–55. 2003. View Article : Google Scholar | |
|
Guo W, XU B, Meng Q, Zheng B, Li X, Liu M and Du XD: Anti-tumor effect of Hinesol on liver cancer via downregulating MEK/ERK and NF-κB pathway in SMMC-7721 and LM3cells. Chin J Pharmacol Toxicol. 32:282. 2018. | |
|
Lobo R, Prabhu KS and Shirwaikar A: Curcuma zedoaria Rosc. (White turmeric): A review of its chemical, pharmacological and ethnomedicinal properties. J Pharm Pharmacol. 61:13–21. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Mao Z, Zhong L, Zhuang X, Liu H and Peng Y: Curcumenol targeting YWHAG inhibits the pentose phosphate pathway and enhances antitumor effects of cisplatin. Evid Based Complement Alternat Med. 2022:39889162022. View Article : Google Scholar : PubMed/NCBI | |
|
Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, et al: Plasma mi RNA s as early biomarkers for detecting hepatocellular carcinoma. Int J Cancer. 137:1679–1690. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yerukala Sathipati S and Ho SY: Novel miRNA signature for predicting the stage of hepatocellular carcinoma. Scie Rep. 10:144522020. View Article : Google Scholar | |
|
Sartorius K, Sartorius B, Winkler C, Chuturgoon A and Makarova J: The biological and diagnostic role of miRNA's in hepatocellular carcinoma. Front Biosci (Landmark Ed). 23:1701–1720. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Qadir MI and Rizvi SZ: miRNA in hepatocellular carcinoma: Pathogenesis and therapeutic approaches. Crit Rev Eukaryot Gene Expr. 27:355–361. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Elhefnawi M, Salah Z and Soliman B: The promise of miRNA replacement therapy for hepatocellular carcinoma. Curr Gene Ther. 19:290–304. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Gao J, Zhou B, Xie J, Zhou G and Chen Y: Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles. Life Sci. 232:1165962019. View Article : Google Scholar : PubMed/NCBI | |
|
Li D, Zhang J and Li J: Role of miRNA sponges in hepatocellular carcinoma. Clin Chim Acta. 500:10–19. 2020. View Article : Google Scholar | |
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy B: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 8:92272018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang R, Zhong L, Sun K, Liu J, Wang Q, Mao D, Fang G and Long F: A study on curcumol influencing proliferation and apoptosis of hepatocellular carcinoma cells through DJ-1/PTEN/PI3K/AKT Pathway. Biomed Res Int. 2022:99127762022. View Article : Google Scholar : PubMed/NCBI | |
|
Kirana C, McIntosh GH, Record IR and Jones GP: Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer. 45:218–225. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wani NA, Zhang B, Teng K, Barajas JM, Motiwala T, Hu P, Yu L, Brüschweiler R, Ghoshal K and Jacob ST: Reprogramming of glucose metabolism by zerumbone suppresses hepatocarcinogenesis. Mol Cancer Res. 16:256–268. 2018. View Article : Google Scholar | |
|
Samad NA, Abdul AB, Rahman HS, Rasedee A, Tengku Ibrahim TA and Keon YS: Zerumbone suppresses angiogenesis in HepG2 cells through inhibition of matrix metalloproteinase-9, vascular endothelial growth factor, and vascular endothelial growth factor receptor expressions. Pharmacogn Mag. 13(Suppl 4): S731–S736. 2017. | |
|
Abdul ABH, Al-Zubairi AS, Tallan ND, Wahab SIA, Zain ZNM, Ruslay S and Syam MM: Anticancer activity of natural compound (zerumbone) extracted from Zingiber zerumbet in human HeLa cervical cancer cells. Int J Pharmacol. 4:1602008. View Article : Google Scholar | |
|
Sakinah SA, Handayani ST and Hawariah LP: Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio. Cancer Cell Int. 7:42007. View Article : Google Scholar : PubMed/NCBI | |
|
Taha MME, Abdul AB, Abdullah R, Ibrahim TA, Abdelwahab SI and Mohan S: Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chem Biol Interact. 186:295–305. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bora KS and Sharma A: Phytochemical and pharmacological potential of Medicago sativa: A review. Pharm Biol. 49:211–220. 2011. View Article : Google Scholar | |
|
Rustaiyan A and Masoudi S: Chemical constituents and biological activities of Iranian Artemisia species. Phytochemistry Lett. 4:440–447. 2011. View Article : Google Scholar | |
|
He ZZ, Yan JF, Song ZJ, Ye F, Liao X, Peng SL and Ding LS: Chemical constituents from the aerial parts of Artemisia minor. J Nat Prod. 72:1198–1201. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Martínez MJA, Del Olmo LMB, Ticona LA and Benito PB: The Artemisia L. genus: A review of bioactive sesquiterpene lactones. Stud Natu Products Chem. 37:43–65. 2012. View Article : Google Scholar | |
|
Suresh J, Mahesh NM, Ahuja J and Santilna KS: Review on Artemisia nilagirica (Clarke) pamp. J Biol Active Products Nat. 1:97–104. 2011. | |
|
He X, Ma W, Hu J, Li T, Geng C, Ma Y, Wang M, Yang K, Zhang X and Chen JJ: Diverse structures and antihepatoma effect of sesquiterpenoid dimers from Artemisia eriopoda by AKT/STAT signaling pathway. Signal Transduct Target Ther. 8:642023. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Chen Q, Liu J, Lai S, Zhang M, Zhen T, Hu H, Gao X, Wong AST and Zeng JZ: Orphan nuclear receptor Nur77 mediates the lethal endoplasmic reticulum stress and therapeutic efficacy of cryptomeridiol in hepatocellular carcinoma. Cells. 11:38702022. View Article : Google Scholar : PubMed/NCBI | |
|
Yu X, Yang FQ, Li SP, Gao JL, Hu G, Lao SC, Conceição EL, Fung KP, Wangl YT and Lee SM: Furanodiene induces G2/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells. Cancer Biol Ther. 6:1044–1050. 2014. | |
|
Yang F, Chen WD, Deng R, Li DD, Wu KW, Feng GK, Li HJ and Zhu XF: Hirsutanol A induces apoptosis and autophagy via reactive oxygen species accumulation in breast cancer MCF-7 cells. J Pharmacol Sci. 119:214–220. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yang F, Chen WD, Deng R, Zhang H, Tang J, Wu KW, Li DD, Feng GK, Lan WJ, Li HJ and Zhu XF: Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: Hirsutanol A inhibits tumor growth through ROS production. J Transl Med. 11:322013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Mao Y, Hou L and Cui X: The effect of beta-elemene on alpha-tubulin polymerization in human hepatoma HepG2 cells. Chin J Cancer Res. 25:770–776. 2013. | |
|
Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo A and Wang W: Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors. Contemp Clin Trials. 27:70–82. 2006. View Article : Google Scholar | |
|
Sun Y, Liu G, Zhang Y, Zhu H, Ren Y and Shen YM: Synthesis and in vitro anti-proliferative activity of β-elemene monosubstituted derivatives in HeLa cells mediated through arrest of cell cycle at the G1 phase. Bioorg Med Chem. 17:1118–1124. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wu B, Jiang Y, Zhu F, Sun D and Huang H: Demethylation effects of elemene on the GSTP1 gene in HCC cell line QGY7703. Oncol Lett. 11:2545–2551. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Qin Y, Guo Y, Wei W, Wang B, Jin H, Sun J, Qi J, Ren S and Zuo Y: Anti-tumor effect of β-elemene in murine hepatocellular carcinoma cell line H22 depends on the level of c-Met downregulation. Biomedicine Preventive Nutr. 2:91–98. 2012. View Article : Google Scholar | |
|
Ni G, Shi GR, Zhang D, Fu NJ, Yang HZ, Chen XG and Yu DQ: Cytotoxic Lignans and Sesquiterpenoids from the Rhizomes of Acorus tatarinowii. Planta Medica. 82:632–638. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JJ, Wei HB, Xu YZ, Hu SC and Gao K: Senedensiscins A-F: Six new eudesmane sesquiterpenoid glucosides from Senecio densiserratus. Tetrahedron. 69:10598–10603. 2013. View Article : Google Scholar | |
|
Yang ML, Chen JJ, Wei HB and Gao K: Cytotoxic sesquiterpenoids from Senecio densiserratus. Phytochemistry Lett. 16:236–240. 2016. View Article : Google Scholar | |
|
Tsevegsuren N, Edrada RA, Lin W, Ebel R, Torre C, Ortlepp S, Wray V and Proksch P: Biologically active natural products from Mongolian medicinal plants Scorzonera divaricata and Scorzonera pseudodivaricata. J Nat Prod. 70:962–967. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Q, He XF, Jiang CX, Zhang W, Shi ZN, Li HF and Zhu Y: Two novel bioactive sulfated guaiane sesquiterpenoid salt alkaloids from the aerial parts of Scorzonera divaricata. Fitoterapia. 124:113–119. 2018. View Article : Google Scholar | |
|
Shang C, Ma YB, Wang Y, He XF, Li TZ and Chen JJ: Artemongolins A-K, undescribed germacrane-guaiane sesquiterpenoid dimers from Artemisia mongolica and their antihepatoma activities. Arch Pharm Res. 46:782–794. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang MF, Li TZ, Ma YB, Ma WJ, Wang YC, Li FJ and Chen JJ: Artemyriantholides A-K, guaiane-type sesquiterpenoid dimers from Artemisia myriantha var. pleiocephala and their antihepatoma activity. Phytochemistry. 222:1141002024. View Article : Google Scholar : PubMed/NCBI | |
|
He XF, Ma YB, Li TZ and Chen JJ: Highly oxygenated guaiane-type sesquiterpene lactones from Artemisia sacrorum and their antihepatoma activity. Phytochemistry. 217:1139302024. View Article : Google Scholar | |
|
Wang X, Li TZ, Ma YB, Ma WJ, Xue D and Chen JJ: Synthesis and antihepatoma activity of guaianolide dimers derived from lavandiolide I. Bioorg Med Chem Lett. 104:1297082024. View Article : Google Scholar : PubMed/NCBI | |
|
Fang JY and Richardson BC: The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 6:322–327. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Meloche S and Pouysségur J: The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene. 26:3227–3239. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yang F, Li J, Zhu J, Wang D, Chen S and Bai X: Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice. Eur J Pharmacol. 754:105–114. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cusimano A, Foderà D, D'Alessandro N, Lampiasi N, Azzolina A, Montalto G and Cervello M: Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway. Cancer Biol Ther. 6:1457–1464. 2007. View Article : Google Scholar | |
|
Wang XD, Meng FC and Mao JX: Progress of natural sesquiterpenoids in the treatment of hepatocellular carcinoma. Front Oncol. 14:14452222024. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Wang T, Sun Y, Huang T and Li C, Fu Y, Li Y and Li C: p53-mediated PI3K/AKT/mTOR pathway played a role in PtoxDpt-induced EMT inhibition in liver cancer cell lines. Oxid Med Cell Longev. 2019:25314932019. | |
|
Kahraman DC, Kahraman T and Cetin-Atalay R: Targeting PI3K/Akt/mTOR pathway identifies differential expression and functional role of IL8 in liver cancer stem cell enrichment. Mol Cancer Ther. 18:2146–2157. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Luedde T and Schwabe RF: NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 8:108–118. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wilson CL, Jurk D, Fullard N, Banks P, Page A, Luli S, Elsharkawy AM, Gieling RG, Chakraborty JB, Fox C, et al: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nat Commun. 6:68182015. View Article : Google Scholar | |
|
Lee C and Cheung ST: STAT3: An emerging therapeutic target for hepatocellular carcinoma. Cancers. 11:16462019. View Article : Google Scholar : PubMed/NCBI | |
|
Boland ML, Chourasis AH and Macleod KF: Mitochondrial dysfunction in cancer. Front Oncol. 3:2922013. View Article : Google Scholar : PubMed/NCBI | |
|
Lee KH, Huang ES, Piantadosi C, Pagano JS and Geissman TA: Cytotoxicity of sesquiterpene lactones. Cancer Res. 31:1649–1654. 1971.PubMed/NCBI | |
|
Lopez-Anton N, Hermann C, Murillo R, Merfort I, Wanner G, Vollmar AM and Dirsch VM: Sesquiterpene lactones induce distinct forms of cell death that modulate human Monocyte-derived macrophage responses. Apoptosis. 12:141–153. 2007. View Article : Google Scholar | |
|
Bai Z, Yao C, Zhu J, Xie Y, Ye XY, Bai R and Xie T: Anti-tumor drug discovery based on natural product β-elemene: Anti-tumor mechanisms and structural modification. Molecules. 26:14992021. View Article : Google Scholar | |
|
Xie T, Li CL and Wang SL: Basic research progress of natural anticancer target drugs of elemene liposomes series. Zhongguo Zhong Xi Yi Jie He Za Zhi. 34:507–512. 2014.In Chinese. PubMed/NCBI | |
|
Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, You Y, Wang S, Chen X, Sui X and Xie T: Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy. Int J Nanomedicine. 13:6279–6296. 2018. View Article : Google Scholar : | |
|
Xie T, Cl L, Wang SL, Zeng ZW, Wang F and Zhao R: Advances in the research of Elemene Liposome series targeted anticancer natural drugs. Chin J Integr Trad West Med. 34:507–512. 2014. | |
|
Li H, Xu K, Pian G and Sun S: Artesunate and sorafenib: Combinatorial inhibition of liver cancer cell growth. Oncol Lett. 18:4735–4743. 2019.PubMed/NCBI | |
|
Yao X, Zhao CR, Yin H, Wang K and Gao JJ: Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carinoma cells. Acta Pharmacol Sin. 41:1609–1620. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Alven S and Aderibigbe BA: Nanoparticles formulations of artemisinin and derivatives as potential therapeutics for the treatment of cancer, leishmaniasis and malaria. Pharmaceutics. 12:7482020. View Article : Google Scholar : PubMed/NCBI | |
|
Pan XW, Huang JS, Liu SR, Shao YD, Xi JJ, He RY, Shi TT, Zhuang RX and Bao JF: Evaluation of the liver targeting and anti-liver cancer activity of artesunate-loaded and glycyrrhetinic acid-coated nanoparticles. Exp Ther Med. 26:5162023. View Article : Google Scholar | |
|
Hermida MA, Kumar JD and Leslie NR: GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. Adv Biol Regul. 65:5–15. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, Wang Q, Wang S, Rong D, Reiter FP, et al: The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 5:872020. View Article : Google Scholar : PubMed/NCBI |
